The **Preclinical Imaging Market** is characterized by a high barrier to entry, largely due to the formidable cost of advanced imaging modalities such as micro-MRI, PET, and multimodal systems. These high capital expenditures, coupled with significant operational and maintenance costs, often place state-of-the-art imaging capabilities out of reach for smaller academic labs and emerging biotech...